DECHENG CAPITAL LLC other names

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}

Adviser Profile

Registration status: Registration Changed to DECHENG CAPITAL LLC

Exempt Reporting Adviser:

qualify for the exemption from registration as an adviser solely to one or more venture capital funds, as defined in rule 203(l)-1


SMA’s:

NO

Private Funds:

0

Contact Info

345 xxxxxxx

Recent News

China Digest: PackGene Biotech, AI chip startup Axera close fresh funding
04/07/2021

Return backers Sequoia Capital China, Cathay Capital China, Kaitai Capital, Oriza Seed, and Decheng Capital re-upped in the current round ... A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across ...

dealstreetasia.com

Alpine Immune Sciences Inc.
04/03/2021

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Barrons

Equillium Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development Update
04/02/2021

LA JOLLA, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory ...

Yahoo Finance

BeyondSpring Inc.
03/29/2021

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Barrons

Equillium Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development Update
03/28/2021

LA JOLLA, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced financial results for the fourth quarter ...

Yahoo Finance

Equillium Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development Update Nasdaq:EQ
03/25/2021

Cash runway into the second half of 2023 Announced positive interim data from EQUATE study in aGVHD Multiple data and regulatory catalysts in 2021 LA JOLLA, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- Equillium,

menafn.com

Private Funds



Employees